Feasibility of mHealth Devices in Monitoring of Heart Rate, Physical Activity and Respiratory Function in Smokers with and without Respiratory Symptoms and COPD
DOI:
https://doi.org/10.12974/2312-5470.2020.06.01Keywords:
COPD, feasibility study, mobile health apps, mHealth, smokers.Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a global public health problem, and continuous monitoring is essential for both its management as well as the management of other chronic diseases. Telemonitoring using mobile health (mHealth) devices has the potential to promote self-management, improve control, increase quality of life, and prevent hospital admissions. Objective: This proof-of-concept study aims to assess feasibility, accuracy, and reproducibility of biosensing (mHealth) devices in monitoring of heart rate, physical activity and respiratory function in smokers with and without respiratory symptoms and COPD. Methods: A total of 3 cohorts, with 9 participants in each, used mHealth devices for 90 days while undergoing the current standard of care. These groups were: 9 “non-COPD,” otherwise healthy, smokers; 9 “grey zone” smokers (forced expiratory volume in 1 second/ forced vital capacity ?0.70 after bronchodilator treatment; COPD Assessment Test ?10); and 9 smokers diagnosed with Stage 1-3 COPD. Two mHealth devices were utilized in the study: (1) the AnaMed Original Equipment Manufacturer device (OEM) that measures distance, energy expenditure, heart rate, and heart rate variability by using photoplethysmographic method and displays the results on a watchface, smartphone or a tablet, and (2) the Air Next mobile spirometry portable device that performs spirometric measurements (FEV1, FVC and FEV1/FVC ratio) by a turbine mechanism and displays the results on a smartphone or a tablet. The mHealth devices were compared against industry standards. Recruitment, retention and adherence rates were 35%, 100%, and 63% respectively. Additionally, a questionnaire was administered to assess the participants’ perceptions of the mHealth technologies used. Results: The AnaMed device was demonstrated as precise in measuring heart rate, and less so when measuring number of steps and meters. It is unreliable in measuring SpO2. It is easy to use, requires no significant technical support. The Air-Next Spirometer is a simple and very precise instrument for detecting obstructive airway diseases which was confirmed when compared to the industry standard. It is easy to use, which could make it especially useful for non-specialized care and in-home setting and other areas. Conclusion: We demonstrated that both devices, AnaMed and AirNext can provide precise measurements or heart rate and spirometric data, and it is feasible to incorporate them into a routine clinical practice for remote monitoring of chronic conditions such as COPD. However, such task would require some efforts to take care of technical and logistical issues, i.e. sending reminders, synching devices with smartphones, communication efforts.
References
Nimmon L, Poureslami I, FitzGerald M. Telehealth Interventions for Management of Chronic Obstructive Lung Disease (COPD) and Asthma. Int J Health Inf Syst Inform. 2013;8(1):37–56. https://doi.org/10.4018/jhisi.2013010103
Lundell S, Holmner ????, Rehn B, Nyberg A, Wadell K. Telehealthcare in COPD: a systematic review and meta- analysis on physical outcomes and dyspnea. Respir Med. 2015 Jan;109(1):11–26. https://doi.org/10.1016/j.rmed.2014.10.008
Cruz J, Brooks D, Marques A. Home telemonitoring effectiveness in COPD: a systematic review. Int J Clin Pract. 2014 Mar;68(3):369–78. https://doi.org/10.1111/ijcp.12345
Pinnock H, Hanley J, McCloughan L, Todd A, Krishan A, Lewis S, Stoddart A, van der Pol M, MacNee W, Sheikh A, Pagliari C, McKinstry B. Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial. BMJ. 2013 Oct 17;347:f6070. https://doi.org/10.1136/bmj.f6070
Bolton C, Waters C, Peirce S, Elwyn Glyn, EPSRCMRC Grand Challenge Team Insufficient evidence of benefit: a systematic review of home telemonitoring for COPD. J Eval Clin Pract. 2011 Dec;17(6):1216–22. https://doi.org/10.1111/j.1365-2753.2010.01536.x
Cartwright M, Hirani SP, Rixon L, Beynon M, Doll H, Bower P, Bardsley M, Steventon A, Knapp M, Henderson C, Rogers A, Sanders C, Fitzpatrick R, Barlow J, Newman SP, Whole Systems Demonstrator Evaluation Team Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial. BMJ. 2013 Feb 26;346:f653. https://doi.org/10.1136/bmj.f653 7] Kenealy TW, Parsons MJG, Rouse APB, Doughty RN, Sheridan NF, Hindmarsh JKH, Masson SC, Rea HH. Telecare for diabetes, CHF or COPD: effect on quality of life, hospital use and costs. A randomised controlled trial and qualitative evaluation. PLoS One. 2015;10(3):e0116188. https://doi.org/10.1371/journal.pone.0116188
Sanchez-Morillo D, Fernandez-Granero MA, Leon-Jimenez A. Use of predictive algorithms in-home monitoring of chronic obstructive pulmonary disease and asthma: A systematic review. Chron Respir Dis. 2016 Aug;13(3):264– 83. https://doi.org/10.1177/1479972316642365
Hollander JE, CarrBG. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020 Apr 30;382(18):1679-1681. https://doi.org/10.1056/nejmp2003539
Tillis W, Bond WF, Svendsen J, Guither S. Implementation of Activity Sensor Equipment in the Homes of Chronic Obstructive Pulmonary Disease Patients. Telemed J E Health. 2017 Nov;23(11):920–929. https://doi.org/10.1089/tmj.2016.0201
Himes BE, Weitzman ER. Innovations in health information technologies for chronic pulmonary diseases. Respir Res. 2016 Apr 05;17:38. https://doi.org/10.1186/s12931-016-0354-3
Antoniades NC, Rochford PD, Pretto JJ, Pierce RJ, Gogler J, Steinkrug J, Sharpe K, McDonald CF. Pilot study of remote telemonitoring in COPD. Telemed J E Health. 2012 Oct;18(8):634–40. https://doi.org/10.1089/tmj.2011.0231
Pradella CO, Belmonte GM, Maia MN, Delgado CS, Luise APT, Nascimento OA, Gazzotti MR, Jardim JR. Home- Based Pulmonary Rehabilitation for Subjects With COPD: A Randomized Study. Respir Care. 2015 Apr;60(4):526– 32. https://doi.org/10.4187/respcare.02994
Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest. 2000 Apr;117(4):1146–61. https://doi.org/10.1378/chest.117.4.1146
Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006 Jun;129(6):1509–15. https://doi.org/10.1378/chest.129.6.1509
Schermer TR, Jacobs J E, Chavannes N H, Hartman J, Folgering H T, Bottema B J, van Weel C. Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD) Thorax. 2003 Oct;58(10):861–6. https://doi.org/10.1136/thorax.58.10.861
Wilt T, Niewoehner D, Kim C, Kane R L, Linabery A, Tacklind J, Macdonald R, Rutks I. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD) Evid Rep Technol Assess (Summ) 2005 Aug;(121):1–7. https://doi.org/10.1037/e439492005-001
Chawla H, Bulathsinghala C, Tejada JP, Wakefield D, ZuWallack R. Physical Activity as a Predictor of Thirty-Day Hospital Readmission
Finkelstein J, Knight A, Marinopoulos S, Gibbons MC, Berger Z, Aboumatar H, Wilson RF, Lau BD, Sharma R, Bass EB. Enabling Patient-Centered Care Through Health Information Technology. Rockville, Maryland, United States: Agency for Healthcare Research and Quality (US); 2012. after a Discharge for a Clinical Exacerbation of Chronic Obstructive Pulmonary Disease. Annals ATS. 2014 Oct;11(8):1203–1209. https://doi.org/10.1513/annalsats.201405-198oc
Mandl KD, Kohane IS. Escaping the EHR trap--the future of health IT. N Engl J Med. 2012 Jun 14;366(24):2240–2. https://doi.org/10.1056/nejmp1203102
Eggleston EM, Weitzman ER. Innovative uses of electronic health records and social media for public health surveillance. Curr Diab Rep. 2014 Mar;14(3):468. https://doi.org/10.1007/s11892-013-0468-7
Sharman, A., Zhussupov, B., Sharman, D., Kim, I. Evaluating Mobile Apps and Biosensing Devices to Monitor Physical Activity and Respiratory Function in Smokers with and Without Respiratory Symptoms or Chronic Obstructive Pulmonary Disease: Protocol for a Proof-of-Concept, Open- Label, Feasibility Study. JMIR Res Protoc. 2020 Mar; 9(3) https://doi.org/10.2196/16461
National Institute for Health Research. 2019. Jun 18,
- 01-28]. Guidance on applying for feasibility studies.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 01;166(1):111–117. https://doi.org/10.1164/ajrccm.166.1.at1102
Sharman A, Zhussupov B, Sharman D, Stambekova A, Yeraliyev S. Cross-Sectional Study of Chronic Obstructive Pulmonary Disease Prevalence Among Smokers, Ex- Smokers, and Never-Smokers in Almaty, Kazakhstan: Study Protocol. JMIR Res Protoc. 2017 Jul 25;6(7):e143. https://doi.org/10.2196/resprot.7422
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct;388(10053):1659–1724. https://doi.org/10.1038/sj.bdj.2015.751
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012 Dec;380(9859):2095–2128.
Friedlander AL, Lynch D, Dyar LA, Bowler RP. Phenotypes of chronic obstructive pulmonary disease. COPD. 2007 Dec;4(4):355–84. https://doi.org/10.1080/15412550701629663
Silverman EK. Exacerbations in Chronic Obstructive Pulmonary Disease: Do They Contribute to Disease Progression? Proceedings of the American Thoracic Society. 2007 Dec 01;4(8):586–590. doi: 10.1513/pats.200706-068th. https://doi.org/10.1513/pats.200706-068th
Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015 Mar 07;385(9971):899–909. https://doi.org/10.1016/s0140-6736(14)60446-3
Woodruff PG, Barr RG, Bleecker E, Christenson SA, Couper D, Curtis JL, Gouskova NA, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Lazarus SC, Martinez FJ,
Paine R, Rennard S, Tashkin DP, Han MK. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N Engl J Med. 2016 May 12;374(19):1811–1821. https://doi.org/10.1056/nejmoa1505971
Genetic Epidemiology of COPD (COPDGene) Investigators Clinical and Radiologic Disease in Smokers With Normal Spirometry. JAMA Intern Med. 2015 Sep;175(9):1539–49.
Mohktar MS, Redmond SJ, Antoniades NC, Rochford PD, Pretto JJ, Basilakis J, Lovell NH, McDonald CF. Predicting the risk of exacerbation in patients with chronic obstructive pulmonary disease using home telehealth measurement data. Artif Intell Med. 2015 Jan;63(1):51–9. https://doi.org/10.1016/j.artmed.2014.12.003
Stroetmann K, Kubitschke L, Robinson S, Stroetmann V, Cullen K, McDaid D. World Health Organization Europe. 2010.
-01-28]. How can telehealth help in the provision of integrated care?
Rubio N, Parker RA, Drost EM, Pinnock H, Weir CJ, Hanley J, Mantoani LC, MacNee W, McKinstry B, Rabinovich RA. Home monitoring of breathing rate in people with chronic obstructive pulmonary disease: observational study of feasibility, acceptability, and change after exacerbation. COPD. 2017 Apr;Volume 12:1221–1231. https://doi.org/10.2147/copd.s120706
Liu L, Stroulia E, Nikolaidis I, Miguel-Cruz A, Rios Rincon A. Smart homes and home health monitoring technologies for older adults: A systematic review. Int J Med Inform. 2016 Jul;91:44–59. https://doi.org/10.1016/j.ijmedinf.2016.04.007
Ho T, Huang C, Chiu H, Ruan S, Tsai Y, Yu C, Lai F, HINT Study Group Effectiveness of Telemonitoring in Patients with Chronic Obstructive Pulmonary Disease in Taiwan-A Randomized Controlled Trial. Sci Rep. 2016 Mar 31;6:23797. https://doi.org/10.1038/srep23797
Pedone C, Chiurco D, Scarlata S, Incalzi RA. Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial. BMC Health Serv Res. 2013 Mar 06;13(1):82. https://doi.org/10.1186/1472-6963-13-82
Hernández Carme, Alonso A, Garcia-Aymerich J, Grimsmo A, Vontetsianos T, García Cuyàs Francesc, Altes Anna Garcia, Vogiatzis I, Garåsen Helge, Pellise L, Wienhofen L, Cano I, Meya M, Moharra Montserrat, Martinez Joan Ignasi, Escarrabill Juan, Roca Josep. Integrated care services: lessons learned from the deployment of the NEXES project. Int J Integr Care. 2015 Mar 31;15(1):e006. https://doi.org/10.5334/ijic.2018
Blumenthal JA, Emery CF, Smith PJ, Keefe FJ, Welty- Wolf K, Mabe S, Martinu T, Johnson JJ, Babyak MA, O’Hayer VF, Diaz PT, Durheim M, Baucom D, Palmer SM. The Effects of a Telehealth Coping Skills Intervention on Outcomes in Chronic Obstructive Pulmonary Disease. Psychosomatic Medicine. 2014;76(8):581–592. https://doi.org/10.1097/psy.0000000000000101
Nowiński A, Romański E, Bieleń P, Bednarek M, Puścińska E, Goljan-Geremek A, Pływaczewski R, Śliwinski P. Pilot program on distance training in spirometry testing — the technology feasibility study. Pneumonol Alergol Pol. 2015 Nov 10;83(6):431– 435. https://doi.org/10.5603/piap.2015.0071
